lystn

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/managing-heart-failure-in-primary-care-podcastFeaturing Alanna Morris, MD, MSc, FHFSA, FACC, FAHA as faculty, moderated by Gregg Sherman, MD. This course will review evidence-based guidelines for early recognition and diagnosis of Heart Failure (HF), development of patient care plans that consider the latest guidelines and clinical data, as well as patient characteristics,  and the benefits of a multi-disciplinary team and shared-decision making approach to improve patient outcomes. Heart failure (HF) is a growing problem that affects an estimated 6.2 million adults in the United States. The availability of effective medical therapies for HF, including newer agents, offers the prospect of improved outcomes. However, HF remains underdiagnosed, and the assessment and management of HF patients may not align with evidence-based guidelines. Primary care providers (PCPs) are frequently the first line of care for patients with HF and are frequently responsible for making timely and accurate diagnoses, initiating therapy, and managing comorbidities.  This activity is certified for CME/CE credit.For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.naceonline.com/courses/managing-heart-failure-in-primary-care-podcast Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Association of Black Cardiologists, Inc. designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 21222. This activity is approved for 0.5 contact hours (which includes 0 hours of pharmacology). This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.